<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: PREDICTIVEtrade mark (Predictable Results and Experience in <z:mp ids='MP_0002055'>Diabetes</z:mp> through Intensification and Control to Target: An International Variability Evaluation) is a large, multi-national, observational study assessing the safety and efficacy of insulin detemir </plain></SENT>
<SENT sid="1" pm="."><plain>We report the study design, population characteristics and baseline observations, including cross-sectional analysis, from 19 911 patients with type 1 or 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Patients with type 1 or 2 <z:mp ids='MP_0002055'>diabetes</z:mp> requiring basal insulin are prescribed insulin detemir and followed up for 12-52 weeks </plain></SENT>
<SENT sid="3" pm="."><plain>Data on demographics, <z:chebi fb="34" ids="35143">haemoglobin</z:chebi> A(1c) (HbA(1c)), fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, within-subject fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> variability and weight are collected from patient records (and/or recall for <z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">hypoglycaemia</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>A negative binomial distribution model is used to assess the influence of predictive/confounding variables on <z:e sem="disease" ids="C0745153" disease_type="Disease or Syndrome" abbrv="">hypoglycaemic episodes</z:e> in insulin-treated patients at baseline </plain></SENT>
<SENT sid="5" pm="."><plain>Multi-factorial analysis of covariance is used to evaluate the association of the variables with current body weight and within-subject fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> variability </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Total <z:e sem="disease" ids="C0745153" disease_type="Disease or Syndrome" abbrv="">hypoglycaemic episodes</z:e> in the 4 weeks prior to study start were 47.5 per patient-year in patients with type 1 and 9.2 per patient-year in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>The frequency of <z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">hypoglycaemia</z:e> in insulin-treated patients showed a significant, positive association with duration of <z:mp ids='MP_0002055'>diabetes</z:mp>, number of insulin injections and fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> variability but was inversely related to HbA(1c), fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> and body mass index </plain></SENT>
<SENT sid="8" pm="."><plain>Weight showed a significant positive association with gender (male &gt; female) and insulin dosage </plain></SENT>
<SENT sid="9" pm="."><plain>Weight was also positively associated with fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> variability in patients with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, and age and number of injections in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: These baseline data showed that, in addition to the established relationship with intensive treatment and HbA(1c), frequency of <z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">hypoglycaemia</z:e> was positively associated with fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> variability </plain></SENT>
<SENT sid="11" pm="."><plain>Follow-up data from PREDICTIVE will provide insights on insulin detemir in <z:mp ids='MP_0002055'>diabetes</z:mp> management </plain></SENT>
</text></document>